ADRIANNA WILLIAMSON: Open Payments
NPI 1285172619 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 73 payments from 15 companies in 2025. Trend: 2023 $1,158 · 2024 $1,069 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $330 |
| Novo Nordisk Inc | 16 | $196 |
| Lilly USA, LLC | 9 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| PFIZER INC. | 3 | $77 |
| Amgen Inc. | 3 | $46 |
| Exact Sciences Corporation | 2 | $41 |
| Tris Pharma Inc | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: MOUNJARO, QULIPTA, VRAYLAR, JARDIANCE, UBRELVY, XIFAXAN, Wegovy, Ozempic.
Industry payments across MS — which companies pay providers there.
